Texas 2021 - 87th Regular

Texas House Bill HCR86

Caption

Expressing support for equitable access to transformative therapies for sickle cell disease.

Impact

If adopted, HCR86 would symbolize a commitment by the Texas legislature to promote equitable healthcare access for individuals suffering from sickle cell disease. By endorsing efforts to enhance the availability of innovative therapies, the resolution aims to address the disparities that patients face in receiving appropriate treatment. The call for increased access to transformative therapies is crucial, especially given the advancements in medical science, such as gene editing, that may lead to effective cures in the future.

Summary

HCR86 is a House Concurrent Resolution expressing support for equitable access to transformative therapies for sickle cell disease. This resolution highlights the significant impact sickle cell disease has on individuals and the healthcare system, noting that it affects approximately 100,000 Americans and imposes a nearly $3 billion economic burden annually. The resolution advocates for increased support and innovation in treatments for this condition, which has historically been neglected in terms of adequate medical care and resources.

Sentiment

The sentiment surrounding HCR86 appears to be overwhelmingly positive, with unanimous support reflected in the legislative votes—142 in favor with no opposition in the House and 30 in favor in the Senate. This consensus indicates a strong legislative commitment to addressing the needs of sickle cell patients and enhancing their quality of life. The resolution is part of a broader initiative to ensure that medical advancements translate into real benefits for underserved communities.

Contention

While HCR86 itself does not introduce new laws or regulations, its passage marks an important recognition of the challenges faced by sickle cell disease patients. Notable points of contention surrounding the resolution may include the historical neglect of this medical condition in policy-making, debate over funding for research and treatment, and the broader implications for healthcare equity. As healthcare policy evolves, the resolution may invigorate discussions about how to ensure that all patients, especially those with chronic conditions, receive comprehensive and effective medical care.

Companion Bills

No companion bills found.

Previously Filed As

TX HB1481

Relating to sickle cell disease health care improvement and the sickle cell task force.

TX HB1488

Relating to sickle cell disease health care improvement and the sickle cell task force.

TX SB1757

Relating to the treatment of and education on sickle cell disease and the sickle cell task force.

TX HB181

Relating to the establishment of the sickle cell disease registry.

TX SCR3

Expressing support for ending "gender-affirming care."

TX SB773

Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.

TX HCR30

Expressing support for geothermal energy production.

TX HR443

Recognizing February 28, 2023, as Rare Disease Day.

TX HB638

Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.

TX HR907

Recognizing April 2023 as Parkinson's Awareness Month and honoring Power for Parkinson's on the occasion of its 10th anniversary.

Similar Bills

No similar bills found.